[indices] CCInfo 29 May 2008

["Leesette Turner" <hamis@iafrica.com>]

CCInfo 15 May 2008

Dear Colleague,

Herewith please find the latest edition of the Electronic news bulletin of The Cochrane Collaboration.

Kind regards
Joy

CCInfo: Electronic news bulletin of The Cochrane Collaboration
29 May 2008

 
Contents:
A. Updates to the Cochrane Manual available
B. New discussion list for Adverse Effects Methods Group
C. Cochrane column in journal - CAM reviews
D. Reporting findings of clinical trials
E. SCT/ImpaCT Trial of the Year Award
F. Job ad - Director of Knowledge Exchange
G. Next Issue of CCInfo


A. Sender: Jini Hetherington [JHetherington@cochrane.org]
     Subject: Updates to the Cochrane Manual available


The updated Cochrane Manual is now available on the Cochrane website at www.cochrane.org/admin/manual.htm, and contains the following: 
 
Section 2.2.11 How to cite our products (citation format for the Cochrane Handbook for Systematic Reviews of Interventions, February 2008) [update]
 
Section 2.4.1 Discretionary Fund [update]

 

Section 2.4.2 Visiting Fellowship [update]

 

XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

 

B. Sender: Su Golder [spg3@york.ac.uk]
    Subject: New discussion list for Adverse Effects Methods Group

The Cochrane Adverse Effects Group was officially registered on the 14 June 2007. The Group has now established a discussion list and invites anyone interested in any aspect of incorporating adverse effects into 
systematic reviews to join, whether it be an interest in searching, inclusion criteria, quality assessment and/or meta-analysis. 

 

To join the discussion list please go to http://lists.cochrane.org/mailman/listinfo/aemg.
For more details on the Group go to; http://aemg.cochrane.org/.

 

XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

 

C. Sender: Eric Manheimer [emanheimer@compmed.umm.edu]
    Subject: Cochrane column in journal - CAM reviews

 

The Cochrane CAM Field column in the journal Explore is designed to promote an awareness of the Cochrane Collaboration and to improve the understanding of Cochrane reviews among complementary and alternative medicine (CAM) researchers and practitioners. Each Explore column typically begins with the reproduction of the abstract of a relevant CAM-related Cochrane review, followed by a commentary on the review. 
 
The current Explore column, by Karen Sherman, is a commentary on the Cochrane review of massage for neck pain, and is available (with subscription) in the May 2008 issue of Explore, at http://www.explorejournal.com/current. The subsequent column, currently in press for the July issue of Explore, is a commentary by Gloria Yeh on the Cochrane review of Tai Chi for rheumatoid arthritis. Although the CAM Field Explore column has been published periodically since May 2005, we have arranged to publish this column more frequently in the future (i.e. columns are planned for every issue of the bi-monthly Explore for the remainder of 2008 and into early 2009).

 

XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

 

D. Sender: Ghersi, Davina [ghersid@who.int]
    Subject: Reporting findings of clinical trials

 

When researchers embark on a clinical trial, they make a commitment to conduct the trial and to report the findings in accordance with basic ethical principles. This includes preserving the accuracy of the results and making both positive and negative results publicly available. However, a significant proportion of healthcare research remains unpublished and, even when it is published, some researchers do not make all of their results available. Selective reporting, regardless of the reason for it, leads to an incomplete and potentially biased view of the trial and its results. For more information please refer to "Reporting the Findings of Clinical Trials" in The Bulletin.

The WHO Registry Platform Working Group on the Reporting of Findings of Clinical Trials has proposed that "the findings of all clinical trials must be made publicly available". On 20th May an online survey will commence, the aim of which will be to obtain feedback on this proposed position. 
To participate in the survey please go to http://www.who.int/ictrp/results/consultation/en/index.html and follow the link.
You are invited and encouraged to participate in the survey and may do so as an individual, or on behalf of an organization. Please be aware that the survey will close at 5.00pm Geneva time on Friday 27th June. We look forward to receiving your contribution. 

 

XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

 

E. Sender: Steve Goodman [sgoodman@jhmi.edu]
    Subject: SCT/ImpaCT Trial of the Year Award

 

See formal announcement below. Thanks to Iain Chalmers and David Sackett for nominating this trial. What is not in this announcement is the fact that the PI says that she got the idea for this trial while 'killing time browsing the Cochrane Library', and being 'horrified' that this widely used treatment, which she had good reasons to believe might be harmful, had never been tested for its long term effects. From the moment she was browsing the Cochrane Library to when the 4-country, >30 site trial of nearly 2000 infants was actually initiated was only 18 months.

Clinical Trial of the Year Award Winner Announced
Inaugural Award to Honor Study of Caffeine and Premature Infants
The Society for Clinical Trials (SCT) and Project ImpACT (Important Achievements of Clinical Trials) announce the winner of the inaugural SCT/ImpACT Clinical Trial of the Year award. The award went to a trial examining the long-term effects of the administration of caffeine in premature infants to alleviate apnea of prematurity, showing a substantial health benefit. Barbara Schmidt, MD, MSc, the trial's principal investigator and the Kristine Sandberg Knisely Chair in Neonatology at the Children's Hospital of Philadelphia, accepted the award on behalf of the Caffeine for Apnea of Prematurity Trial Group. Her trial was the first to receive this award, which was announced on May 20 at the Society for Clinical Trial's annual meeting in St. Louis, on International Clinical Trials Day.
 
The Society for Clinical Trials www.sctweb.org/  MailScanner has detected a possible fraud attempt from "mail.uottawa.ca" claiming to be www.sctweb.org/ 
Project ImpACT www.projectimpact.info  MailScanner has detected a possible fraud attempt from "mail.uottawa.ca" claiming to be www.projectimpact.info/Home/aboutus.cfm

XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

 

F. Sender: Alexandra Kaneb [ali.kaneb@rayberndtson.ca]
    Subject:  Job ad - Director of Knowledge Exchange

 

Position: Director of Knowledge Exchange
Organisation: Canadian Centre on Substance Abuse
Location: Ottawa, Canada
Application deadline: 6 June 2008
Contact: For full details contact Eric Lathrop or Alexandra Kaneb at (613) 742-3213 or a.kaneb@rayberndtson.ca or submit your resume and related information online at www.rayberndtson.ca/en/careers/7781.

 

XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

 

G. Sender: Cheryl Arratoon [cochrane@uottawa.ca]
    Subject: Next Issue of CCInfo

 

The next issue of CCInfo will be published 12 June 2008.
Please submit your items to cochrane@uottawa.ca and include "CCInfo" in the subject line. Unless you request otherwise, your submissions to the CCInfo may be duplicated in other regular Cochrane Collaboration news channels such as Cochrane News and the Cochrane Collaboration web site, at the discretion of the editors.

 

Best regards,
Cheryl Arratoon
Knowledge Broker
Canadian Cochrane Network and Centre
1 Stewart St, 2nd Floor
Ottawa, ON, Canada  K1N 6N5
Email: cochrane@uottawa.ca
Web: www.ccnc.cochrane.org

 

XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

 

To subscribe to or unsubscribe from the CCInfo list, please go to http://lists.cochrane.org/mailman/listinfo/ccinfo, or contact the Editor at cochrane@uottawa.ca